Do you want to read an article? Please log in or register.
LUNG CANCER SURGICAL MANAGEMENT DURING THE OUTBREAK OF COVID-19
Lung, Respiratory and Thoracic Cancer
Related content
RECOMMENDED
Lung, Respiratory and Thoracic CancerCOVID-19
Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer.
Liao Z, Rivin Del Campo E, Salem A, Pang Q, Liu H, Lopez Guerra JL
doi: 10.1016/j.lungcan.2020.05.029.
Lung, Respiratory and Thoracic Cancer
Alternative Multidisciplinary Management Options for Locally Advanced Non-Small Cell Lung Cancer During the COVID-19 Global Pandemic
J Thorac Oncol.
Kumar S, Chmura S, Robinson C, Lin SH, Gadgeel SM, Donington J, Feliciano J, Stinchcombe TE, Werner-Wasik M, Edelman MJ, Moghanaki D
doi: 10.1016/j.jtho.2020.04.016.
Lung, Respiratory and Thoracic Cancer
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
ESMO Open.
Passaro A, Addeo A, Von Garnier C, Blackhall F, Planchard D, Felip E, Dziadziuszko R, de Marinis F, Reck M, Bouchaab H, Peters S
doi: 10.1136/esmoopen-2020-000820.
Further Publications
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
Eur J Cancer.
de Joode K, Dumoulin DW, Tol J, Westgeest HM, Beerepoot LV, van den Berkmortel FWPJ, Mutsaers PGNJ, van Diemen NGJ, Visser OJ, Oomen-de Hoop E, Bloemendal HJ, van Laarhoven HWM, Hendriks LEL, Haanen JBAG, de Vries EGE, Dingemans AC, van der Veldt AAM, DOCC Investigators.
doi: 10.1016/j.ejca.2020.09.027.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers
★ 1
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
doi: 10.1158/2159-8290.CD-20-0596.
COVID-19
Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak
Cancer Discov.
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q, Xiong Y, Xiong H, Wang C, Chen C, Xiong F, Zhang Y, Peng Y, Ge S, Zhen B, Yu T, Wang L, Wang H, Liu Y, Chen Y, Mei J, Gao X, Li Z, Gan L, He C, Li Z, Shi Y, Qi Y, Yang J, Tenen DG, Chai L, Mucci LA, Santillana M, Cai H
doi: 10.1158/2159-8290.
Breast Cancer
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium
Breast Cancer Res Treat.
Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, Bleicher RJ, Lyons JA, Sarantou T, Baron PL, Stevens RE, Boolbol SK, Anderson BO, Shulman LN, Gradishar WJ, Monticciolo DL, Plecha DM, Nelson H, Yao KA
doi: 10.1007/s10549-020-05644-z.
Lung, Respiratory and Thoracic Cancer
Treatment guidance for lung cancer patients during the COVID-19 pandemic
J Thorac Oncol.
Dingemans AC, Soo RA, Jazieh AR, Rice SJ, Kim YT, Teo LL, Warren GW, Xiao SY, Smit EF, Aerts JG, Yoon SH, Veronesi G, De Cobelli F, Ramalingam SS, Garassino MC, Wynes MW, Behera M, Haanen J, Lu S, Peters S, Ahn MJ, Scagliotti GV, Adjei AA, Belani CP
doi: 10.1016/j.jtho.2020.05.001.
COVID-19
Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
Cancer Treat Rev.
Slimano F, Baudouin A, Zerbit J, Toulemonde-Deldicque A, Thomas-Schoemann A, Chevrier R, Daouphars M, Madelaine I, Pourroy B, Tournamille JF, Astier A, Ranchon F, Cazin JL, Bardin C, Rioufol C
doi: 10.1016/j.ctrv.2020.102063.